Metoclopramide: Difference between revisions

(Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template))
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(One intermediate revision by the same user not shown)
Line 137: Line 137:
  |?Has Route=Route
  |?Has Route=Route
  |?Has Population=Population
  |?Has Population=Population
  |format=broadtable
  |format=table
  |headers=plain
  |headers=plain
  |link=subject
  |mainlabel=-
  |sort=Has Indication
  |sort=Has Indication
  |limit=50
  |limit=50

Latest revision as of 21:57, 20 March 2026

General

  • Type: antiemetics
  • Dosage Forms: 5mg, 10mg; 5mg/5 mL; IM; IV
  • Common Trade Names: Reglan

Adult Dosing

GERD

  • Chronic symptoms: 10-15mg PO/IM/IV qac and qhs
  • Max: x12wk; intermittent symptoms: up to 20mg PO/IM/IV x 1 before symptoms

Diabetic gastroparesis

  • 10mg PO/IM/IV qac and qhs
  • Max: x12wk

Nausea/vomiting prevention, chemo-related

  • 1-2mg/kg IV q2-3h

Nausea/vomiting prevention, postop

  • 10mg IM/IV x 1

small bowel intubation

  • 10mg IV x 1

Radiologic exam

  • 10mg IV x 1

Palliative medicine

  • 10mg subcutaneously or orally 6-hourly and/or 30mg via CSCI over 24 hours

Pediatric Dosing

GERD

  • 0.1-0.2mg/kg PO/IM/IV QID
  • Max: 0.8mg/kg/24h x 12wk

Nausea/vomiting prevention, chemo-related

  • 1-2mg/kg IV q2-4h

Nausea/vomiting prevention, postop

  • 0.1-0.2mg/kg IV x1

Special Populations

  • Pregnancy Rating: B
  • Lactation risk: Safety Unknown
  • Renal Dosing
    • Adult: CrCl 41-50: decrease dose 25%; CrCl 10-40: decrease dose 50%; CrCl <10: decrease dose 75%; HD/PD: no supplement
    • Pediatric: CrCl 41-50: decrease dose 25%; CrCl 10-40: decrease dose 50%; CrCl <10: decrease dose 75%; HD/PD: no supplement
  • Hepatic Dosing
    • Adult: no adjustment
    • Pediatric: no adjustment

Contraindications

  • Allergy to class/drug
  • pheochromocytoma
  • seizure disorder
  • GI bleeding or perforation
  • GI obstruction
  • caution if depression
  • caution if Parkinson disease
  • caution if NADH methemoglobin reductase deficiency
  • caution if hypertension
  • caution if CHF
  • caution if cirrhosis
  • caution if dibetes mellitus
  • caution if renal impairment
  • caution if neonates
  • caution if pediatric patients
  • caution if elderly patients, esp. female

Adverse Reactions

Serious

  • extrapyramidal symptoms
  • dystonia, acute
  • parkinsonism
  • tardive dyskinesia
  • neuroleptic malignant syndrome
  • seizures
  • depression
  • suicidality
  • hallucinations
  • leukopenia
  • neutropenia
  • agranulocytosis
  • methemoglobinemia
  • CHF, acute
  • AV block
  • SVT
  • hypertension
  • angioedema
  • hepatotoxicity
  • withdrawal symptoms if abrupt discontinuation

Common

  • drowsiness
  • restlessness
  • fatigue
  • anxiety
  • insomnia
  • headache
  • confusion
  • dizziness
  • depression
  • extrapyramidal symptoms
  • galactorrhea
  • amenorrhea
  • gynecomastia
  • hyperprolactinemia
  • impotence
  • hyperaldosteronism
  • fluid retention
  • hypotension
  • hypertension
  • bradycardia
  • nausea
  • diarrhea
  • urinary frequency
  • incontinence
  • rash
  • urticaria
  • visual disturbance

Pharmacology

  • Half-life: 5-6h
  • Metabolism: liver minimally; CYP450: unknown
  • Excretion: urine 85% (20% unchanged), bile/feces 5%
  • Mechanism of Action: exact mechanism of action unknown; sensitizes tissues to acetylcholine, stimulating upper GI tract motility; antagonizes central and peripheral dopamine receptors, producing antiemetic effects

Comments

Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Headache10 mg IVAlternative abortiveIVAdult
Headache during pregnancy10mg IM/IV or POAdjunct antiemetic/headache treatmentIM/IV/POAdult
Hyperemesis gravidarum5-10 mg q8hr2nd line antiemeticIVAdult
Migraine headache10 mg IV2nd line abortiveIVAdult
Migraine headache10 mg IVAlternative abortiveIVAdult
Vertigo10-20 mg TIDAntidopaminergicIV/POAdult

See Also

References